347 related articles for article (PubMed ID: 6940191)
1. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74.
Gerard C; Showell HJ; Hoeprich PD; Hugli TE; Stimler NP
J Biol Chem; 1985 Mar; 260(5):2613-6. PubMed ID: 3972798
[TBL] [Abstract][Full Text] [Related]
3. Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a.
Zimmermann B; Damerau B; Vogt W
Hoppe Seylers Z Physiol Chem; 1980; 361(6):915-24. PubMed ID: 7399411
[TBL] [Abstract][Full Text] [Related]
4. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
Fernandez HN; Hugli TE
J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
[TBL] [Abstract][Full Text] [Related]
5. C4a: the third anaphylatoxin of the human complement system.
Gorski JP; Hugli TE; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
[TBL] [Abstract][Full Text] [Related]
6. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
7. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
9. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
10. Amino-acid sequence and disulfide linkages of the anaphylatoxin, des-Arg omega-C5a, from porcine serum.
Zimmermann B; Vogt W
Hoppe Seylers Z Physiol Chem; 1984 Feb; 365(2):151-8. PubMed ID: 6714942
[TBL] [Abstract][Full Text] [Related]
11. Human C5a des Arg increases vascular permeability.
José PJ; Forrest MJ; Williams TJ
J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
[TBL] [Abstract][Full Text] [Related]
12. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
Perez HD; Chenoweth DE; Goldstein IM
J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
[TBL] [Abstract][Full Text] [Related]
13. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
Abdullah NA; Assem ES; Damerau B
Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
[TBL] [Abstract][Full Text] [Related]
14. C5 neoepitopes appearing during activation.
Inoue K
Complement Inflamm; 1989; 6(3):219-22. PubMed ID: 2472923
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
Huey R; Bloor CM; Kawahara MS; Hugli TE
Am J Pathol; 1983 Jul; 112(1):48-60. PubMed ID: 6859228
[TBL] [Abstract][Full Text] [Related]
16. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
Stimler-Gerard NP
Complement; 1986; 3(3):137-51. PubMed ID: 3026723
[TBL] [Abstract][Full Text] [Related]
17. Purification and partial characterization of human and porcine C3a anaphylatoxin.
Hugli TE; Vallota EH; Müller-Eberhard HJ
J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
[TBL] [Abstract][Full Text] [Related]
18. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
Fernandez HN; Hugli TE
J Immunol; 1976 Nov; 117(5 Pt 1):1688-94. PubMed ID: 1002996
[TBL] [Abstract][Full Text] [Related]
19. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
Kew RR; Webster RO
J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
[TBL] [Abstract][Full Text] [Related]
20. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]